ID: ALA3350340

Max Phase: Preclinical

Molecular Formula: C12H19BrClNO2

Molecular Weight: 288.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](N)Cc1cc(OC)c(Br)cc1OC.Cl

Standard InChI:  InChI=1S/C12H18BrNO2.ClH/c1-4-9(14)5-8-6-12(16-3)10(13)7-11(8)15-2;/h6-7,9H,4-5,14H2,1-3H3;1H/t9-;/m0./s1

Standard InChI Key:  BFYFGBMMVCXAIO-FVGYRXGTSA-N

Associated Targets(non-human)

Felis catus 3858 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 288.19Molecular Weight (Monoisotopic): 287.0521AlogP: 2.75#Rotatable Bonds: 5
Polar Surface Area: 44.48Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.94CX LogP: 2.78CX LogD: 0.36
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.91Np Likeness Score: 0.20

References

1. Standridge RT, Howell HG, Tilson HA, Chamberlain JH, Holava HM, Gylys JA, Partyka RA, Shulgin AT..  (1980)  Phenylalkylamines with potential psychotherapeutic utility. 2. Nuclear substituted 2-amino-1-phenylbutanes.,  23  (2): [PMID:7359529] [10.1021/jm00176a010]

Source